Home Markets Novo Nordisk cuts forecasts, shares rise ahead of FDA ban on Wegovy copycats

Novo Nordisk cuts forecasts, shares rise ahead of FDA ban on Wegovy copycats

May 07, 2025 comments off

Original source: https://www.investing.com/news/stock-market-news/obesity-drugmaker-novo-nordisk-cuts-2025-outlook-posts-q1-profit-above-forecast-4027000

You May Also Like

Why South Korea’s stock market represents the purest AI trade

Abuse survivors approve $800 million settlement with Archdiocese of New York

Trump set to announce Audi plan to build US factory in Georgia, source says

Apax, Nordic Capital and Dalmore circling UK supplier JLA Group – Bloomberg

Couche-Tard proposes up to $8 billion offer for Cumberland Farms, The Times reports

France spared Moody’s ratings downgrade as it struggles with unrest